The global influenza diagnostics market is expected to reach USD 3.43 billion by 2030, at a CAGR of 7% during the forecast period 2022 to 2030. Asia Pacific is expected to grow the fastest during the forecast period.
A viral infection known as influenza, or the flu, primarily affects the human respiratory system, which includes the nose, throat, and lungs. Numerous immunoassay tests are used in influenza diagnostics to help find influenza A and B viral nucleoprotein antigens in respiratory specimens. Rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays are a few of the frequently used diagnostic techniques. The global influenza diagnostics market is primarily driven by the rising incidence of various chronic conditions that enhance the risk of contracting influenza, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc. In addition, the growing elderly population, who are more vulnerable to respiratory tract infections, is fuelling the market's expansion. Additionally, the increasing use of miniaturized devices and the expanding availability of sophisticated diagnostic immunoassay formats favour the global influenza diagnostics market. The development of CLIA-waived point-of-care molecular influenza tests and the movement in consumer preferences from centralized laboratories to decentralized point-of-care testing are also contributing to the market's expansion.
Get an overview of this study by requesting a free sample
Growth in Influenza - R&D efforts for efficient detection and diagnosis have intensified due to the rising global frequency of influenza. Most research efforts focus on creating effective and efficient diagnostic tools for influenza viruses, which will fuel market growth and development. In addition, several factors are anticipated to support the growth of the influenza diagnostics market during the forecast period, including the rise in government initiatives to combat influenza outbreaks, an increase in the global geriatric population, the development of advanced technology, and an increase in cardiovascular and diabetes diseases. As a consequence of rising healthcare spending, expanding R&D, and several other positive aspects, the influenza diagnostics market will grow throughout the forecast period.
Lack of Skilled Professionals- On the other hand, the market's growth rate will be hampered by a lack of qualified and experienced personnel and an uncertain regulatory environment for the licensing of new diagnostic tests. A lack of skilled workers and healthcare facilities in developing nations will challenge the influenza diagnostics market.
Growing Awareness-An early identification of the flu results in better treatment and longer-term care. Early diagnosis enables patients and medical personnel to make various critical care and support options. Getting a proper diagnosis as soon as one notices cognitive symptoms associated with a particular medical illness has many benefits. One of the most successful and widely used methods for diagnosing numerous infectious disorders linked to bacterial, viral, or protozoal infections is laboratory evaluation. Various infectious disorders are detected via isothermal nucleic acid amplification tests, biochemical characterization, immunoassays, polymerase chain reaction, and next-generation sequencing.
Stringent Regulations- Regulations for product approval that are too strict prevent the market from expanding more quickly. Players must obtain de novo designation - to commercialize influenza tests for home use in the United States. This certification, however, is only given if the risk is low and there isn't a direct equivalent technology on the market that exhibits a comparable degree of safety and efficacy.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest market for the global influenza diagnostics market, with a 39% share of the market revenue in 2022.
North America currently dominates the influenza diagnostics market with a 39% market revenue share in 2022. Over the course of the forecast period, the increasing prevalence of influenza is anticipated to drive the regional market. For instance, according to data from MedAlertHelp, between 5% and 20% of Americans will receive an annual influenza diagnosis in 2022. Furthermore, 20,000 flu-related deaths, 380,000 influenza-related hospitalizations, and 16 million influenza-related doctor visits were reported in the 2019–2020 season, per data released by the Centers for Disease Control and Prevention in October 2021. In the upcoming years, market growth is predicted to be positively impacted by the rising disease burden. RIDTs are widely accessible throughout the region, according to statistics from the Centers for Disease Control and Prevention (CDC) published in 2021.
Asia Pacific is anticipated to witness the fastest growth during the forecast period. Due to the ageing population, rising number of influenza occurrences, rising focus of key players in the diagnostics market on this region, growing government investments to support the healthcare sector, favourable reimbursement scenario for diagnostic procedures, efficient healthcare infrastructure followed by its accessibility, and rising demand for beekeeping services.
North America Region Influenza Diagnostics Market Share in 2022 - 39%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The test type segment is divided into traditional diagnostic tests and molecular diagnostic assays. The traditional diagnostic tests segment dominated the market, with a market share of around 63% in 2022. The rise in patient management and surveillance testing for influenza diagnoses in clinical settings explains this. Many RIDTs have received approval for use in homes and offices, and CLIA has approved their usage in point-of-care settings. For instance, ProtonDX announced in August 2022 that its quick and portal diagnostics tests would monitor respiratory diseases, including influenza, among athletes and coaches during the Commonwealth Games 2022. Thus, expanding flu surveillance and monitoring during public events is expected to encourage the development of RIDTs.
The end-user segment is divided into laboratories, hospitals, and others. Over the forecast period, the hospital segment is expected to grow at the fastest CAGR of 7.1%. Hospitalizations are common throughout the seasonal flu season. The hospitalizations draw attention to the disease's potential severity. Since influenza can sometimes exacerbate pre-existing medical disorders or cause new problems necessitating hospitalization is expected to propel the segment’s growth. For instance, in 2021–2022, around 58.0% of flu patients in the U.S. who were hospitalized also had hypertension issues, 44% had cardiovascular problems, and approximately 40.0% had pregnancy-related problems. Because underlying medical disorders like autoimmune diseases are becoming more prevalent, individuals are forced to choose inpatient treatment. It is believed that newly developed, technologically improved flu diagnostic tests, such as those incorporating point-of-care technology (POCT) and flu testing, will make it easier to monitor the older population. Furthermore, POCT is anticipated to boost the number of flu tests in rural Asia Pacific regions.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2022 | USD 2 billion |
Market size value in 2030 | USD 3.43 billion |
CAGR (2022 to 2030) | 7% |
Historical data | 2019-2020 |
Base Year | 2021 |
Forecast | 2022-2030 |
Regional Segments | Test Type, End-User |
Segments | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
As per The Brainy Insights, the size of the influenza diagnostics market was valued at USD 2 billion in 2022 to USD 3.43 billion by 2030.
The global influenza diagnostics market is growing at a CAGR of 7% during the forecast period 2022-2030.
North America emerged as the largest region for the global influenza diagnostics market.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Type
4.3.2. Market Attractiveness Analysis By End-User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Growth in Influenza
5.3. Restraints
5.3.1. Lack of Skilled Professionals
5.4. Opportunities
5.4.1. Growing Awareness
5.5. Challenges
5.5.1. Lack of Skilled Professionals
6. Global Influenza Diagnostics Market Analysis and Forecast, By Type
6.1. Segment Overview
6.2. Traditional Diagnostic Test
6.3. Molecular Diagnostic Assay
7. Global Influenza Diagnostics Market Analysis and Forecast, By End-User
7.1. Segment Overview
7.2. Laboratories
7.3. Hospitals
7.4. Others
8. Global Influenza Diagnostics Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Influenza Diagnostics Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Influenza Diagnostics Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. 3M
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Becton, Dickinson, and Company (Bd)
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Meridian Bioscience, Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Abbott Laboratories, Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Hologic, Inc.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. SA Scientific
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Thermo Fisher Scientific, Inc.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Sekisui Diagnostics
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. F. Hoffmann-LA Roche AG
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Quidel Corporation
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
2. Global Traditional Diagnostic Test, Influenza Diagnostics Market, By Region, 2019-2030 (USD Billion)
3. Global Molecular Diagnostic Assay, Influenza Diagnostics Market, By Region, 2019-2030 (USD Billion)
4. Global Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
5. Global Laboratories, Influenza Diagnostics Market, By Region, 2019-2030 (USD Billion)
6. Global Hospitals, Influenza Diagnostics Market, By Region, 2019-2030 (USD Billion)
7. Global Others, Influenza Diagnostics Market, By Region, 2019-2030 (USD Billion)
8. North America Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
9. North America Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
10. U.S. Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
11. U.S. Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
12. Canada Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
13. Canada Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
14. Mexico Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
15. Mexico Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
16. Europe Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
17. Europe Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
18. Germany Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
19. Germany Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
20. France Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
21. France Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
22. U.K. Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
23. U.K. Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
24. Italy Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
25. Italy Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
26. Spain Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
27. Spain Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
28. Asia Pacific Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
29. Asia Pacific Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
30. Japan Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
31. Japan Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
32. China Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
33. China Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
34. India Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
35. India Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
36. South America Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
37. South America Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
38. Brazil Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
39. Brazil Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
40. Middle East and Africa Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
41. Middle East and Africa Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
42. UAE Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
43. UAE Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
44. South Africa Influenza Diagnostics Market, By Type, 2019-2030 (USD Billion)
45. South Africa Influenza Diagnostics Market, By End-User, 2019-2030 (USD Billion)
List of Figures
1. Global Influenza Diagnostics Market Segmentation
2. Global Influenza Diagnostics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Influenza Diagnostics Market Attractiveness Analysis By Type
9. Global Influenza Diagnostics Market Attractiveness Analysis By End-User
10. Global Influenza Diagnostics Market Attractiveness Analysis By Region
11. Global Influenza Diagnostics Market: Dynamics
12. Global Influenza Diagnostics Market Share By Type (2022 & 2030)
13. Global Influenza Diagnostics Market Share By End-User (2022 & 2030)
14. Global Influenza Diagnostics Market Share By Regions (2022 & 2030)
15. Global Influenza Diagnostics Market Share By Company (2021)
This study forecasts global, regional, and country revenue from 2019 to 2030. The Brainy Insights has segmented the global influenza diagnostics market based on the below-mentioned segments:
Global Influenza Diagnostics Market by Type:
Global Influenza Diagnostics Market by End-User:
Global Influenza Diagnostics Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date